Discover Log In Sign Up
AXON
Axon Enterprise, Inc.
Summary
Business
Earnings Call
Valuation
Profitability
Financial Health
Yearly Return 10Y annualized return is excellent at 34.9% per year
Earnings Expectations AXON has met or exceeded earnings expectations in all recent quarters (10/10)
Positive Strong Gross Profit Margin
Positive Healthy Net Profit Margin
Positive Good Return on Equity
Positive Strong Liquidity Ratios
Positive Low Debt Levels
Positive Strong Revenue Growth
Positive Robust Customer Trust and Adoption
Positive Diverse Customer Base
Positive Innovative Product Development
Positive Strong Future Bookings
Positive Positive Market Trends
Negative High Price-to-Earnings Ratio
Negative Elevated Price-to-Sales Ratio
Negative Low Operating Profit Margin
Negative Low Cash Ratio
Negative Political and Regulatory Risks

Overall, Axon demonstrates a strong business model with significant competitive advantages and a positive future outlook driven by innovation and a diverse customer base, despite facing some political risks.

Analysis Date: February 25, 2025
Last Updated: March 11, 2025

+1900%
+34.9% per year

Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.

Country US
Exchange NASDAQ
Industry Aerospace & Defense
Sector Industrials
Market Cap $43.33B
CEO Mr. Patrick W. Smith

Axon Enterprise, Inc. is a company that makes safety tools for police and law enforcement. They are best known for their TASER devices, which help officers safely subdue suspects without using lethal force. Axon also provides body cameras and software that help police departments manage video and evidence. Their goal is to make law enforcement more effective and accountable by providing the right technology and support.

Streams of revenue

Software and Sensors Segment: 59%
Taser Weapons Segment: 41%

Geographic Distribution

UNITED STATES: 89%
Non-US: 11%

Core Products

๐Ÿš“
Axon Fleet In-car video systems
๐Ÿ“„
Axon Records Records management
๐Ÿ’พ
Axon Evidence Digital evidence mgmt
๐Ÿ”ซ
TASER Devices Non-lethal weapons
๐Ÿ“ท
Axon Body Cameras Wearable cameras

Business Type

B2Government Business to Government

Competitive Advantages

๐Ÿ†
Brand Recognition Axon's strong brand identity and reputation for reliability in law enforcement products enhance customer loyalty.
๐Ÿ”—
Integrated Solutions Offering a comprehensive suite of hardware and software products creates a seamless ecosystem for law enforcement agencies.
๐Ÿ”ง
Innovative Technology Continuous investment in R&D leads to cutting-edge products like TASER 7 and advanced software solutions that outpace competitors.
๐Ÿค
Strategic Partnerships Collaborations with tech firms like Fusus enhance product offerings and expand operational capabilities for clients.
๐Ÿ“ˆ
Recurring Revenue Model Subscription-based software services provide stable and predictable revenue streams, reducing reliance on hardware sales.

Key Business Risks

๐Ÿ
Market Competition Intense competition from other defense and technology firms could erode market share and pressure pricing.
๐Ÿ’ป
Technology Adoption Rapid advancements in technology may lead to obsolescence of existing products if Axon fails to innovate and adapt.
๐Ÿ›ก๏ธ
Cybersecurity Threats As a provider of digital evidence management solutions, Axon faces risks of data breaches and cyberattacks that could compromise sensitive information.
โš–๏ธ
Regulatory Compliance Changes in regulations governing law enforcement and use of CEDs could impact product sales and operational practices.
๐Ÿ‘ฎ
Dependency on Law Enforcement Agencies Heavy reliance on government contracts and law enforcement agencies for sales could pose risks if budgets are cut or if agencies seek alternative suppliers.

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Graham Value Metrics

Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.

Intrinsic Value

Estimated fair value based on Graham's formula

$61.59

Current Market Price: $502.87

IV/P Ratio: 0.12x (>1.0 indicates undervalued)

Margin of Safety

Gap between intrinsic value and market price

-717.0%

Graham recommended a minimum of 20-30% margin of safety

Higher values indicate a greater potential discount to fair value

Graham Criteria Checklist

Benjamin Graham's value investing checklist for AXON

No Positive earnings (5+ years)
No Dividend history (5+ years)
No P/E ratio โ‰ค 20 (100.90)
No P/B ratio โ‰ค 1.5 (16.31)
Yes Current ratio โ‰ฅ 2.0 (2.30x)
Yes Long-term debt < Net current assets (0.56x)
No Margin of safety (-717.0%)
No AXON does not meet all Graham criteria

ROE: 18.409964038757305

ROA: None

Gross Profit Margin: 59.51179654687001

Net Profit Margin: 18.050775001511333

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Healthy Net Profit Margin

18.05%
Net Profit Margin

AXON demonstrates a solid net profit margin of 18.05%, showcasing effective cost management and strong profitability relative to its sales.

Good Return on Equity

18.41%
Return on Equity

With a return on equity of 18.41%, AXON is effectively generating profit from its equity base, indicating strong performance in utilizing shareholder funds.

Low Operating Profit Margin

2.80%
Operating Profit Margin

The operating profit margin is only 2.80%, suggesting that a large portion of revenue is consumed by operational costs, which could limit profitability growth.

About Profitability Metrics

Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.

Return on Equity (ROE)

Measures how efficiently a company uses its equity to generate profits

18.41%

10% 15%

Higher values indicate better returns for shareholders

TTM (as of 2025-04-25)

Gross Profit Margin

Percentage of revenue retained after accounting for cost of goods sold

59.51%

20% 40%

Higher values indicate better efficiency in production

TTM (as of 2025-04-25)

Net Profit Margin

Percentage of revenue retained after accounting for all expenses

18.05%

8% 15%

Higher values indicate better overall profitability

TTM (as of 2025-04-25)

Strong Liquidity Ratios

2.30
Current Ratio
2.04
Quick Ratio

AXON's current ratio of 2.30 and quick ratio of 2.04 indicate solid liquidity, suggesting it can comfortably meet short-term obligations.

Low Debt Levels

0.31
Debt-to-Equity Ratio
0.16
Debt-to-Assets Ratio

With a debt-to-equity ratio of 0.31 and a debt-to-assets ratio of 0.16, AXON has a manageable level of debt, reflecting strong financial health.

Low Cash Ratio

0.46
Cash Ratio

The cash ratio of 0.46 suggests that while liquidity is strong, there may be concerns regarding immediate cash availability to cover current liabilities.

About Financial Health Metrics

Financial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.

Debt to Equity Ratio

Total debt divided by total equity

0.31x

1.0x 2.0x

Lower values indicate less financial leverage and risk

Less than 1.0 is conservative, 1.0-2.0 is moderate, >2.0 indicates high risk

Q4 2024

Current Ratio

Current assets divided by current liabilities

2.30x

1.0x 2.0x

Higher values indicate better short-term liquidity

Less than 1.0 is concerning, 1.0-2.0 is adequate, greater than 2.0 is good

Q4 2024

Meeting Expectations

10 /10

Higher values indicate better execution and credibility

Recent Results

Beat earnings
2025-02-25 +51.8%
Beat earnings
2024-11-07 +20.8%
Beat earnings
2024-08-06 +17.6%
Beat earnings
2024-05-06 +21.7%
Beat earnings
2024-02-27 +30.2%
Beat earnings
2023-11-07 +34.2%
Beat earnings
2023-08-08 +79.0%
Beat earnings
2023-05-09 +91.3%
Beat earnings
2023-02-28 +40.0%
Beat earnings
2022-11-08 +30.4%

EPS

1.37
Estimated
2.08
Actual
+51.82%
Difference

Strong Revenue Growth

$2 billion
Annual Revenue
30%+
Revenue Growth Rate

Axon has demonstrated strong financial performance, achieving over $2 billion in revenue, nearly double the revenue reported two years ago, with consistent growth of over 30% for three consecutive years.

Robust Customer Trust and Adoption

2x increase
TASER 10 Orders vs TASER 7

Axon's products have garnered strong customer feedback, which reflects a high level of trust and satisfaction. The TASER 10 has been particularly well-received, with orders outpacing the previous model by 2x.

Diverse Customer Base

50% sequential growth in Q4
International Bookings Growth

The company has expanded its customer base beyond US state and local law enforcement, with significant international bookings growth, indicating a broadening market reach.

No weaknesses identified.

Innovative Product Development

10 deals in Q4
AI Era Plan Deals

Axon is actively investing in new technologies, including AI, drones, and robotics, which are expected to drive future growth. The AI Era Plan has shown rapid adoption, indicating strong demand for innovative solutions.

Strong Future Bookings

$10 billion
Future Contracted Bookings

Axon has a robust pipeline with over $10 billion in future contracted bookings, providing a solid foundation for sustained growth in the coming years.

Positive Market Trends

$20 billion for drone-related opportunities
Total Addressable Market (TAM)

The company is poised to benefit from major tech trends such as increased AI integration, connectivity, and enhanced public safety solutions, which are expected to expand their market opportunities.

Political and Regulatory Risks

Axon's investment in their headquarters is at risk due to political challenges in Arizona, which could impact their operational stability and growth strategy if not resolved.

Home Screener Search Profile

During the beta period, we're currently displaying stocks from the S&P 500 index only. More stocks will be added soon.

Loading...